glp 1 drugs and hashimoto's GLP-1 medication side effects for diabetes weight loss GLP-1 Agonists: A Comprehensive Overview
Description
The LEADER trial demonstrated a significant reduction in the rate of cardiovascular death, nonfatal MI, or nonfatal stroke in patients with type II diabetes treated with liraglutide
2021 Nov 10;12:786732
Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians
Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes
The results were compelling: GLP-1 RAs significantly reduced the risks of major adverse cardiac events (MACE), kidney disease progression, and even overall mortality
